VMS Industry Wants Into CBD Market, Plus Enforcement On Firms Already There

FDA policy change making hemp and CBD eligible for use a dietary ingredients should include requiring regulatory compliance by companies already marketing products with the ingredients, representatives of firms and industry trade groups said at public hearing. Requirements include submitting to FDA pre-market notifications of proof of a reasonable expectation safety for an ingredient's intended use. "Ensure the rule of law is upheld by barring any company illegally marketing CBD or hemp-derived dietary ingredients from submitting an NDI for the period of time that their products have been illegally marketed," says NOW Health exec Aaron Secrist.

Hemp to CBD process horizontal infographic, healthcare and medical illustration about cannabis - Vector

A level playing field for developing and launching dietary supplements containing cannabis-derived ingredients should come with any decision to deem the substances dietary ingredients, industry stakeholders recommend to the US Food and Drug Administration.

An FDA policy change should include requiring full regulatory compliance by companies already marketing food and supplement products containing hemp and cannabidiol, representatives of vitamin, mineral and supplement

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation